Norflex and Kaposi's sarcoma classical type - a phase IV clinical study of FDA data

Summary:

We study 1,775 people who take Norflex or have Kaposi's sarcoma classical type. No report of Kaposi's sarcoma classical type is found in people who take Norflex.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.


On Jul, 24, 2022

No report is found.


What is Norflex?

Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,758 Norflex users for its effectiveness, alternative drugs and more.

What is Kaposi's Sarcoma Classical Type?

Kaposi's sarcoma classical type (a tumour caused by human herpes virus in mid age group) is found to be associated with 7 drugs and 4 conditions by eHealthMe.

Do you take Norflex and have Kaposi's sarcoma classical type?

Check whether Kaposi's sarcoma classical type is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Norflex:

Kaposi's sarcoma classical type treatments and more:

COVID vaccines that are related to Kaposi's sarcoma classical type:

How severe was Kaposi's sarcoma classical type and when was it recovered:

Expand to all the drugs that have ingredients of orphenadrine citrate:

All the drugs that are associated with Kaposi's sarcoma classical type:

All the conditions that are associated with Kaposi's sarcoma classical type:

How the study uses the data?

The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: